138 related articles for article (PubMed ID: 25987094)
1. Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
Ge NJ; Shi ZY; Yu XH; Huang XJ; Wu YS; Chen YY; Zhang J; Yang YF
Asian Pac J Cancer Prev; 2015; 16(9):4103-7. PubMed ID: 25987094
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.
Zheng YB; Huang JW; Zhan MX; Zhao W; Liu B; He X; Li Y; Hu BS; Lu LG
Tumour Biol; 2014 Nov; 35(11):11473-81. PubMed ID: 25123269
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Wu YS; Bao DK; Dai JY; Chen C; Zhang HX; Yang Y; Xing JL; Huang XJ; Wan SG
Asian Pac J Cancer Prev; 2015; 16(3):1051-6. PubMed ID: 25735330
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus.
Yu X; Ge N; Guo X; Shen S; Liang J; Huang X; Wan S; Xing J; Huang Q; Yang Y
PLoS One; 2014; 9(4):e93416. PubMed ID: 24718422
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
8. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma.
Song Y; Xing H; Zhou L; Zhang N; Yang M
Arch Toxicol; 2021 Sep; 95(9):3063-3070. PubMed ID: 34251499
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of insulin‑like growth factor-2 receptor in human hepatocellular carcinoma and the influence of transarterial chemoembolization.
Lautem A; Simon F; Hoppe-Lotichius M; Mittler J; Vollmar J; Schad A; Düber C; Galle PR; Otto G; Zimmermann T; Lang H
Oncol Rep; 2019 Apr; 41(4):2299-2310. PubMed ID: 30720132
[TBL] [Abstract][Full Text] [Related]
11. Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
Bettinger D; Spode R; Glaser N; Buettner N; Boettler T; Neumann-Haefelin C; Brunner TB; Gkika E; Maruschke L; Thimme R; Schultheiss M
BMC Gastroenterol; 2017 Aug; 17(1):98. PubMed ID: 28797231
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.
Zhang H; Guo X; Dai J; Wu Y; Ge N; Yang Y; Ji J; Zhang H
Med Oncol; 2014 Nov; 31(11):278. PubMed ID: 25355558
[TBL] [Abstract][Full Text] [Related]
13. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
14. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
[TBL] [Abstract][Full Text] [Related]
15. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.
Cabibbo G; Genco C; Di Marco V; Barbara M; Enea M; Parisi P; Brancatelli G; Romano P; Craxì A; Cammà C
Aliment Pharmacol Ther; 2011 Jul; 34(2):196-204. PubMed ID: 21564144
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization.
Liu J; Wang D; Zhou J; Wang L; Zhang N; Zhou L; Zeng J; Liu J; Yang M
Arch Toxicol; 2021 May; 95(5):1621-1629. PubMed ID: 33713148
[TBL] [Abstract][Full Text] [Related]
17. Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
Zhang G; Xiao Y; Tan J; Liu H; Fan W; Li J
J Transl Med; 2024 Jun; 22(1):543. PubMed ID: 38844930
[TBL] [Abstract][Full Text] [Related]
18. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
19. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
